BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 18704136)

  • 1. [Deactivating pacemakers in terminally ill patients].
    Hotvedt R
    Tidsskr Nor Laegeforen; 2008 Aug; 128(15):1680. PubMed ID: 18704136
    [No Abstract]   [Full Text] [Related]  

  • 2. Deactivating cardiac pacemakers and implantable cardioverter defibrillators in terminally ill patients.
    Beca JP; Rosselot E; Asenjo R; Anguita V; Quevedo R
    Camb Q Healthc Ethics; 2009; 18(3):236-40. PubMed ID: 19460224
    [No Abstract]   [Full Text] [Related]  

  • 3. Should implantable cardioverter-defibrillators and permanent pacemakers in patients with terminal illness be deactivated? Deactivating implantable cardioverter-defibrillators and permanent pacemakers in patients with terminal illness. An ethical distinction.
    Kay GN; Bittner GT
    Circ Arrhythm Electrophysiol; 2009 Jun; 2(3):336-9; discussion 339. PubMed ID: 19808484
    [No Abstract]   [Full Text] [Related]  

  • 4. Should implantable cardioverter-defibrillators and permanent pacemakers in patients with terminal illness be deactivated? Deactivating permanent pacemaker in patients with terminalillness. Patient autonomy is paramount.
    Zellner RA; Aulisio MP; Lewis WR
    Circ Arrhythm Electrophysiol; 2009 Jun; 2(3):340-4; discussion 340. PubMed ID: 19808485
    [No Abstract]   [Full Text] [Related]  

  • 5. When is deactivation of artificial pacing and AICD illegal, immoral, and unethical?
    Silveira MJ
    Am J Geriatr Cardiol; 2003; 12(4):275-6. PubMed ID: 14619876
    [No Abstract]   [Full Text] [Related]  

  • 6. Deactivating implanted cardiac devices in terminally ill patients: practices and attitudes.
    Mueller PS; Jenkins SM; Bramstedt KA; Hayes DL
    Pacing Clin Electrophysiol; 2008 May; 31(5):560-8. PubMed ID: 18439169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethical analysis of withdrawal of pacemaker or implantable cardioverter-defibrillator support at the end of life.
    Mueller PS; Hook CC; Hayes DL
    Mayo Clin Proc; 2003 Aug; 78(8):959-63. PubMed ID: 12911044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medicolegal issues arising when pacemaker and implantable cardioverter defibrillator devices are deactivated in terminally ill patients.
    McGeary A; Eldergill A
    Med Sci Law; 2010 Jan; 50(1):40-4. PubMed ID: 20349694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ethics of pacemaker deactivation in terminally ill patients.
    Bevins MB
    J Pain Symptom Manage; 2011 Jun; 41(6):1106-10. PubMed ID: 21621131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deactivating implantable cardioverter defibrillators.
    Ross HM
    Ann Intern Med; 2005 Nov; 143(9):690; author reply 691. PubMed ID: 16263895
    [No Abstract]   [Full Text] [Related]  

  • 11. Treating or Killing? The Divergent Moral Implications of Cardiac Device Deactivation.
    Pilkington BC
    J Med Philos; 2020 Jan; 45(1):28-41. PubMed ID: 31889187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethical considerations for discontinuing pacemakers and automatic implantable cardiac defibrillators at the end-of-life.
    Morgenweck CJ
    Curr Opin Anaesthesiol; 2013 Apr; 26(2):171-5. PubMed ID: 23403711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deactivating implantable cardioverter defibrillators.
    Lynn J
    Ann Intern Med; 2005 Nov; 143(9):691; author reply 691. PubMed ID: 16263897
    [No Abstract]   [Full Text] [Related]  

  • 14. Pacemakers and end-of-life decisions.
    Lampert R; Hayes D
    JAMA; 2011 May; 305(18):1858-9; author reply 1859. PubMed ID: 21558514
    [No Abstract]   [Full Text] [Related]  

  • 15. The ethical and legal implications of deactivating an implantable cardioverter-defibrillator in a patient with terminal cancer.
    England R; England T; Coggon J
    J Med Ethics; 2007 Sep; 33(9):538-40. PubMed ID: 17761824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deactivation of pacemakers and implantable cardioverter-defibrillators.
    Kramer DB; Mitchell SL; Brock DW
    Prog Cardiovasc Dis; 2012; 55(3):290-9. PubMed ID: 23217433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deactivation of implanted cardioverter-defibrillators at the end of life: results of the EHRA survey.
    Marinskis G; van Erven L;
    Europace; 2010 Aug; 12(8):1176-7. PubMed ID: 20663788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Considerations in Patients With Cardiac Implantable Electronic Devices at End of Life.
    Gura MT
    AACN Adv Crit Care; 2015; 26(4):356-63. PubMed ID: 26484996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deactivation of automatic implantable cardioverter-defibrillators in hospice and home care patients at the end of life.
    Kirk TW
    Home Healthc Nurse; 2008; 26(7):431-7. PubMed ID: 18622221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Terminal sedation, euthanasia, and causal roles.
    Birnbacher D
    MedGenMed; 2007 May; 9(2):48. PubMed ID: 17955103
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.